Literature DB >> 19059460

Mechanisms and functions of agonist-independent activation in the angiotensin II type 1 receptor.

Hiroshi Akazawa1, Noritaka Yasuda, Issei Komuro.   

Abstract

The angiotensin II (AngII) type 1 (AT(1)) receptor is a seven-transmembrane G protein-coupled receptor, and is involved in regulating the physiological and pathological process of the cardiovascular system. Systemically and locally generated AngII has agonistic action on AT(1) receptor, but recent studies have demonstrated that AT(1) receptor inherently shows spontaneous activity even in the absence of AngII. Furthermore, mechanical stress can activate AT(1) receptor by inducing conformational switch without the involvement of AngII, and induce cardiac hypertrophy in vivo. These agonist-independent activities of AT(1) receptor can be inhibited by inverse agonists, but not by neutral antagonists. Considerable attention has been directed to molecular mechanisms and clinical implications of agonist-independent AT(1) receptor activation, and inverse agonist activity emerges as an important pharmacological parameter for AT(1) receptor blockers that will improve efficacy and expand therapeutic potentials in cardiovascular medicine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059460     DOI: 10.1016/j.mce.2008.11.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease.

Authors:  Robert M Carey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.

Authors:  Jason R Cook; Harikiran Nistala; Francesco Ramirez
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug

3.  Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.

Authors:  Kwangseok Hong; Guiling Zhao; Zhongkui Hong; Zhe Sun; Yan Yang; Philip S Clifford; Michael J Davis; Gerald A Meininger; Michael A Hill
Journal:  J Physiol       Date:  2016-10-13       Impact factor: 5.182

4.  Elevated pressure causes endothelial dysfunction in mouse carotid arteries by increasing local angiotensin signaling.

Authors:  Yingzi Zhao; Sheila Flavahan; Susan W Leung; Aimin Xu; Paul M Vanhoutte; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

5.  Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.

Authors:  Koichi Yamamoto; Mitsuru Ohishi; Christopher Ho; Theodore W Kurtz; Hiromi Rakugi
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

6.  Angiotensin II Type 1 Receptor Mechanoactivation Involves RGS5 (Regulator of G Protein Signaling 5) in Skeletal Muscle Arteries: Impaired Trafficking of RGS5 in Hypertension.

Authors:  Kwangseok Hong; Min Li; Zahra Nourian; Gerald A Meininger; Michael A Hill
Journal:  Hypertension       Date:  2017-10-23       Impact factor: 10.190

7.  A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.

Authors:  Lingyun Ren; Chuangyan Wu; Kai Yang; Shanshan Chen; Ping Ye; Jie Wu; Anchen Zhang; Xiaofan Huang; Ke Wang; Peng Deng; Xiangchao Ding; Manhua Chen; Jiahong Xia
Journal:  J Am Heart Assoc       Date:  2018-01-22       Impact factor: 5.501

8.  Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals.

Authors:  Jarosław Janc; Michał Suchański; Magdalena Mierzchała-Pasierb; Ewa Woźnica-Niesobska; Lidia Łysenko; Patrycja Leśnik
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

9.  Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.

Authors:  Chizuru Yabumoto; Hiroshi Akazawa; Rie Yamamoto; Masamichi Yano; Yoko Kudo-Sakamoto; Tomokazu Sumida; Takehiro Kamo; Hiroki Yagi; Yu Shimizu; Akiko Saga-Kamo; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Jun-Ichi Suzuki; Yasushi Sakata; Etsuko Uejima; Issei Komuro
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

10.  Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.

Authors:  Shijun Wang; Hui Gong; Guoliang Jiang; Yong Ye; Jian Wu; Jieyun You; Guoping Zhang; Aijun Sun; Issei Komuro; Junbo Ge; Yunzeng Zou
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.